Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neimark

Showing results (241-250 of 263) with videos related to

Pageof 27
Sort By:
Biomolecules|June 2, 2021
Regulatory Action of Plasma from Patients with Obesity and Diabetes towards Muscle Cells Differentiation and Bioenergetics Revealed by the C2C12 Cell Model and MicroRNA AnalysisNatalya V Khromova, Anton V Fedorov, Yi Ma, et al.
Expert Review of Cardiovascular Therapy|November 21, 2019
Cardiac remodeling in obesity and after bariatric and metabolic surgery; is there a role for gastro-intestinal hormones?Elijah Sanches, Marieke Timmermans, Besir Topal, et al.
Inflammatory Bowel Diseases|February 28, 2020
Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM StudyWalter Reinisch, Remo Panaccione, Peter Bossuyt, et al.
Gut|July 10, 2019
Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trialRemo Panaccione, Jean-Frederic Colombel, Simon P L Travis, et al.
Alimentary Pharmacology & Therapeutics|July 26, 2024
Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid-free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's diseaseStefan Schreiber, Raymond K Cross, Remo Panaccione, et al.
Psychiatric Services (Washington, D.C.)|March 2, 2016
Independent Contractors in Public Mental Health Clinics: Implications for Use of Evidence-Based PracticesRinad S Beidas, Rebecca E Stewart, Courtney Benjamin Wolk, et al.
Biomeditsinskaia Khimiia|July 16, 2016
[Regulation of ABCA1 and ABCG1 gene expression in the intraabdominal adipose tissue]V V Miroshnikova, A A Panteleeva, E A Bazhenova, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 14, 2017
Preoperative <sup>18</sup>F-FDG-PET/CT vs Contrast-Enhanced CT to Identify Regional Nodal Metastasis among Patients with Head and Neck Squamous Cell CarcinomaJoshua K Cho, Thomas J Ow, Andrew Y Lee, et al.
Journal of Crohn'S & Colitis|October 5, 2023
Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 TrialMarc Ferrante, Peter M Irving, Maria T Abreu, et al.
Bulletin of Experimental Biology and Medicine|November 29, 2019
Effects of Bariatric Surgeries on the Size of Myocardial Infarction and Ghrelin Level in Rats with Experimental Decompensated Type 2 Diabetes MellitusO V Kornyushin, D L Sonin, Ya G Toropova, et al.
Pageof 27

Showing results (241-250 of 263) with videos related to

Sort By:
Pageof 27
Biomolecules|June 2, 2021
Regulatory Action of Plasma from Patients with Obesity and Diabetes towards Muscle Cells Differentiation and Bioenergetics Revealed by the C2C12 Cell Model and MicroRNA AnalysisNatalya V Khromova, Anton V Fedorov, Yi Ma, et al.
Expert Review of Cardiovascular Therapy|November 21, 2019
Cardiac remodeling in obesity and after bariatric and metabolic surgery; is there a role for gastro-intestinal hormones?Elijah Sanches, Marieke Timmermans, Besir Topal, et al.
Inflammatory Bowel Diseases|February 28, 2020
Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM StudyWalter Reinisch, Remo Panaccione, Peter Bossuyt, et al.
Gut|July 10, 2019
Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trialRemo Panaccione, Jean-Frederic Colombel, Simon P L Travis, et al.
Alimentary Pharmacology & Therapeutics|July 26, 2024
Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid-free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's diseaseStefan Schreiber, Raymond K Cross, Remo Panaccione, et al.
Psychiatric Services (Washington, D.C.)|March 2, 2016
Independent Contractors in Public Mental Health Clinics: Implications for Use of Evidence-Based PracticesRinad S Beidas, Rebecca E Stewart, Courtney Benjamin Wolk, et al.
Biomeditsinskaia Khimiia|July 16, 2016
[Regulation of ABCA1 and ABCG1 gene expression in the intraabdominal adipose tissue]V V Miroshnikova, A A Panteleeva, E A Bazhenova, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 14, 2017
Preoperative <sup>18</sup>F-FDG-PET/CT vs Contrast-Enhanced CT to Identify Regional Nodal Metastasis among Patients with Head and Neck Squamous Cell CarcinomaJoshua K Cho, Thomas J Ow, Andrew Y Lee, et al.
Journal of Crohn'S & Colitis|October 5, 2023
Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 TrialMarc Ferrante, Peter M Irving, Maria T Abreu, et al.
Bulletin of Experimental Biology and Medicine|November 29, 2019
Effects of Bariatric Surgeries on the Size of Myocardial Infarction and Ghrelin Level in Rats with Experimental Decompensated Type 2 Diabetes MellitusO V Kornyushin, D L Sonin, Ya G Toropova, et al.
Pageof 27